SGRY Stock Analysis: Buy, Sell, or Hold?
SGRY - Surgery Partners, Inc. Common Stock
$15.46
0.24 (1.58%)
▲
5d:
+8.64%
30d:
+14.94%
90d:
+28.3%
BUY
MODERATE Confidence
Analysis Updated: Jun 25, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Distribution
None View Scanner →
Strength: 4.8/10
Get Alerted When SGRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SGRY shows positive signals but monitor for confirmation. Market pricing in 2.3% decline. Moderate conviction.
💡 BUY OPPORTUNITY: SGRY shows positive signals but monitor for confirmation. Market pricing in 2.3% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.85
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$19.78
21.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SGRY is currently trading at $15.46, which is considered slightly high relative to its 30-day fair value range of $13.39 to $14.60. The stock's valuation (Forward PE: 23.6) is in line with its historical norms (25.3). Remarkably, the market is currently pricing in an annual earnings decline of 2.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SGRY is in a downtrend. The price is approaching resistance at $14.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SGRY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.95 (+16.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SGRY is in a downtrend. The price is approaching resistance at $14.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SGRY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.95 (+16.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$13.39 -
$14.60
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.8%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($17.95)
Trading Range Analysis
30-Day Trading Range
$13.39 -
$14.60
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$13.09
Resistance Level
$14.21
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.63
Wall Street Target
$17.95
(+16.1%)
Revenue Growth (YoY)
4.5%
Profit Margin
-2.3%
Valuation Discount vs History
-2.3% cheaper
PE vs Historical
23.6 vs 25.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.3%
(market-implied from PE analysis)
1-Year Target
$15.10
(-2%)
2-Year Target
$14.76
(-5%)
3-Year Target
$14.42
(-7%)
3-Yr Target (if PE normalizes)
(PE: 24→25)
$15.44
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.6, Growth: 46.4%)
$48.50
(+214%)
Base:
(SPY PE: 21.8, Growth: 46.4%)
$44.70
(+189%)
Bear:
(PE: 18.5, Growth: 46.4%)
$37.99
(+146%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.6 to 25.3
Stabilization Target:
$16.55
(+7.1%)
PE Expansion Potential:
+7.1%
Share & Embed Analysis
Last updated: June 25, 2026 7:37 PM ET
Data refreshes hourly during market hours. Next update: 8:37 PM
Data refreshes hourly during market hours. Next update: 8:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
David T Doherty
SELL
8867 shares
2026-03-16
Jason Eric Evans
SELL
20400 shares
2026-03-16
Danielle Burkhalter
SELL
3469 shares
2026-03-13
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 62 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 58 HOLD |
Advanced SGRY Option Strategies
Professional options setups generated by AI based on today's SGRY price and gamma walls.
